GlassScriptPhysician profile
Jason Levy
NPI 1437505518
$55,403.89
in general payments reported to CMS, 2019-2025
32 companies · $850 in 2025
The $850 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $85.00 · 2021: $51K · 2022: $774 · 2023: $108 · 2024: $1,388 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.03 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,268.99 | 2019-2025 | Ams 700, Rezum Generator |
| Coloplast Corp | $718.66 | 2019-2025 | |
| Edap Technomed INC | $714.00 | 2024 | |
| Photocure INC | $301.41 | 2021-2025 | Cysview |
| Sumitomo Pharma America, INC. | $227.14 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $115.00 | 2019 | |
| Blue Earth Diagnostics | $114.69 | 2019 | |
| Endo Pharmaceuticals INC. | $96.88 | 2021-2023 | Xiaflex |
| Janssen Scientific Affairs, LLC | $92.26 | 2019 | |
| Janssen Biotech, INC. | $85.00 | 2020 | |
| Myriad Genetic Laboratories, INC. | $83.15 | 2023-2025 | Prolaris |
| Abbvie INC. | $78.77 | 2023-2025 | |
| Laborie Medical Technologies Corp. | $64.46 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Endo USA, INC. | $47.58 | 2024-2025 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $33.33 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $27.90 | 2025 | Spinraza |
| Innovation Technologies INC | $26.94 | 2022 | |
| Caris Mpi, INC. | $25.05 | 2025 | Mi Cancer Seek |
| C. R. Bard, INC. & Subsidiaries | $24.10 | 2019 | |
| Calyxo, INC. | $23.11 | 2024 | Cvac Aspiration System |
| Teleflex LLC | $23.10 | 2022 | |
| Olympus America INC. | $23.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $22.98 | 2025 | Dupixent |
| Ferring Pharmaceuticals INC. | $22.29 | 2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $22.15 | 2025 | |
| Dendreon Pharmaceuticals LLC | $21.58 | 2019 | |
| Tolmar, INC. | $21.14 | 2024 | |
| Procept Biorobotics Corporation | $19.69 | 2022 | |
| Profound Medical Corp. | $18.51 | 2025 | Tulsa-Pro |
| Medtronic USA, INC. | $14.54 | 2019 | |
| Foundation Medicine, INC. | $13.25 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.